Research Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children

Virology Journal

Volumn 7, Issue 1, 2010, Pages

  Jin, Yingkang ^a   Xie, Zhengde ^a   Lu, Gen ^a   Yang, Shuang ^a   Shen, Kunling ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 2; EPSTEIN BARR VIRUS ANTIGEN 3C; IMMEDIATE EARLY PROTEIN BZLF1; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS DNA; BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; BZLF1 GENE; CASE CONTROL STUDY; CHILD; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EPSTEIN BARR VIRUS TYPE 1; EPSTEIN BARR VIRUS TYPE 2; GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEMOPHAGOCYTIC SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MIXED INFECTION; MONONUCLEOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; CHEMISTRY; CHINA; CLASSIFICATION; GENETIC POLYMORPHISM; GENETICS; INFANT; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRESCHOOL CHILD; VIROLOGY;

BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHINA; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS;

EID: 77951972513     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-92     Document Type: Article

References (22)

1. Kieff E, Liebowitz D: Epstein-Barr virus and its replication. In Virology 2nd edition. Edited by: Fields BN, Knipe DM, Chanock RM, Hirsh MS, Melnick JL, Monath T P, Roizman B. New York, N.Y: Raven Press, Ltd.; 1990:1889-1920.
2. Rickinson AB, Kieff E: Epstein-Barr virus. In Fields virology Volume 2. 4th edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott. Williams & Wilkins; 2001:2575-2627.
3. Dambaugh T, Hennessy K, Chamnankit L, Kieff E: U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 1984, 81:7632-7636.
4. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A: Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990, 64:4084-4092.
5. Chen HL, Lung ML, Chan KH, Griffin BE, Ng MH: Tissue distribution of Epstein-Barr virus genotypes. J Virol 1996, 70:7301-7305.
6. Buck M, Cross S, Krauer K, Kienzle N, Sculley TB: A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle. J Gen Virol 1999, 80:441-445.
7. Brooks JM, Croom-Carter DS, Leese AM, Tierney RJ, Habeshaw G, Rickinson AB: Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains. J Virol 2000, 74:1801-1809.
8. Gutierrez MI, Ibrahim MM, Dale JK, Greiner TC, Straus SE, Bhatia K: Discrete alterations in the BZLF1 promoter in tumor and non-tumor associated Epstein-Barr virus. J Natl Cancer Inst 2002, 94:1757-1763.
9. Martini M, Capello D, Serraino D, Navarra A, Pierconti F, Cenci T, Gaidano G, Larocca LM: Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. J Infection 2007, 54:298-306.
10. Hamblin TJ, Hussain J, Akbar AN, Tang YC, Smith JL, Jones DB: Immunological reason for chronic ill health after infectious mononucleosis. Br Med J 1983, 287:85-88.
11. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007, 48:124-131.
12. Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S: Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005, 80:64-69.
13. Christensson B, Braconier JH, Winqvist I, Relander T, Dictor M: Fulminant course of infectious mononucleosis with virus-associated hemophagocytic syndrome. Scand J Infect Dis 1987, 19:373-379.
14. Imashuku S: Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997, 66:135-151.
15. Ross CW, Schnitzer B, Weston BW, Hanson CA: Chronic active Epstein-Barr virus infection and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1991, 115:470-474.
16. Tong JHM, Lo WK, Au FWL, Huang D, To Re K: Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. J Natl Cancer Inst 2003, 95:1008-1009.
17. Chen ML, Tsau CN, Liang CL, Shu CH, Huang CR, Suliltzeanu D, Shih TL, Chang YS: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992, 7:2131-2140.
18. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G: Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991, 72:2399-2409.
19. Craigs D, Thmas C, Shigeru T: Diagnosis of Epstein-Barr virus-associated diseases. Cri Rev Onc 2002, 40:37-38.
20. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T: Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001, 98:280-286.
21. Khanim F, Yao QY, Niedobitek G, Rickinson AB, Young LS: Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996, 88:3491-3501.
22. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M: Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996, 88:242-251.